BAP1 Loss Makes Liver Cancers Vulnerable to CDK4/6 Inhibitors
Genome-wide CRISPR screens reveal BAP1 drives adaptive resistance to CDK4/6 inhibitors via epigenetic reprogramming in hepatobiliary cancers.
4,153 articles in this topic
Genome-wide CRISPR screens reveal BAP1 drives adaptive resistance to CDK4/6 inhibitors via epigenetic reprogramming in hepatobiliary cancers.
A 1,138-patient UK study maps distinct cognitive and psychiatric signatures for PSP, CBS, MSA, and Parkinson's disease to sharpen early diagnosis.
New research reveals CD21 as a molecular switch that initiates TLR7-dependent extrafollicular B cell differentiation, driving autoantibody production in lupus.
A major review reveals how cellular senescence and biological aging clocks intersect to reshape cancer immunity and treatment strategy.
A 70-study meta-analysis finds plyometrics significantly improves jump height, sprint speed, agility, and body fat in athletically trained adults.
A meta-analysis of 52 studies finds transgender women's physical fitness is comparable to cisgender women's after gender-affirming hormone therapy.
A comprehensive 2025 review reveals how targeted diet, exercise, and behavioral changes can halt or reverse MASLD progression.
A sweeping 2025 review maps the dose, intensity, and pattern of physical activity needed to cut cardiovascular disease and mortality risk.
A landmark review traces how epigenetic editing — rewriting gene expression without touching DNA — is entering its first clinical trials.
Scientists engineered lipid nanoparticles that deliver base editors to two organs simultaneously, offering a potential cure for alpha-1 antitrypsin deficiency.
New gene editing tools seekRNA and bridgeRNA push beyond CRISPR's constraints, promising more precise therapies and broader genomic reach.
A 2025 scoping review maps how machine learning, LLMs, and VR are transforming EMS education from intubation drills to disaster prep.